Literature DB >> 24132166

Promise of human induced pluripotent stem cells in skin regeneration and investigation.

Manabu Ohyama1, Hideyuki Okano2.   

Abstract

Induced pluripotent stem cell (iPSC) technology has initiated a new era in biomedical science. The skin has been realized as an ideal platform for iPSC applications; unlike other organs, the skin is easily accessible, highly proliferative, and reconstitutable. Currently, skin equivalents can be generated from iPSCs not only from healthy individuals but also from patients with genodermatoses, providing novel platforms for dissecting disease pathophysiology and establishing cell-based therapy. With their developmental plasticity, iPSCs may also enable the regeneration of skin appendages. The iPSC technology may provide novel remedies for intractable disorders, once key issues particularly, safety concerns, are cleared.

Entities:  

Mesh:

Year:  2013        PMID: 24132166     DOI: 10.1038/jid.2013.376

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  40 in total

1.  Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells.

Authors:  Su-Yi Tsai; Britta Am Bouwman; Yen-Sin Ang; Soo Jeong Kim; Dung-Fang Lee; Ihor R Lemischka; Michael Rendl
Journal:  Stem Cells       Date:  2011-06       Impact factor: 6.277

2.  Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype.

Authors:  A Li; P J Simmons; P Kaur
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 3.  Strategies to enhance epithelial-mesenchymal interactions for human hair follicle bioengineering.

Authors:  Manabu Ohyama; Ophelia Veraitch
Journal:  J Dermatol Sci       Date:  2013-02-28       Impact factor: 4.563

4.  Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice.

Authors:  Satoshi Nori; Yohei Okada; Akimasa Yasuda; Osahiko Tsuji; Yuichiro Takahashi; Yoshiomi Kobayashi; Kanehiro Fujiyoshi; Masato Koike; Yasuo Uchiyama; Eiji Ikeda; Yoshiaki Toyama; Shinya Yamanaka; Masaya Nakamura; Hideyuki Okano
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

5.  Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.

Authors:  Steven J Kattman; Alec D Witty; Mark Gagliardi; Nicole C Dubois; Maryam Niapour; Akitsu Hotta; James Ellis; Gordon Keller
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

6.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

7.  In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.

Authors:  Giovanni Amabile; Robert S Welner; Cesar Nombela-Arrieta; Anna Morena D'Alise; Annalisa Di Ruscio; Alexander K Ebralidze; Yevgenya Kraytsberg; Min Ye; Olivier Kocher; Donna S Neuberg; Konstantin Khrapko; Leslie E Silberstein; Daniel G Tenen
Journal:  Blood       Date:  2012-12-04       Impact factor: 22.113

8.  Transforming growth factor-beta promotes deposition of collagen VII in a modified organotypic skin model.

Authors:  A König; L Bruckner-Tuderman
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

9.  Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

Authors:  Fulvio Mavilio; Graziella Pellegrini; Stefano Ferrari; Francesca Di Nunzio; Enzo Di Iorio; Alessandra Recchia; Giulietta Maruggi; Giuliana Ferrari; Elena Provasi; Chiara Bonini; Sergio Capurro; Andrea Conti; Cristina Magnoni; Alberto Giannetti; Michele De Luca
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

10.  Generation of human melanocytes from induced pluripotent stem cells.

Authors:  Shigeki Ohta; Yoichi Imaizumi; Yohei Okada; Wado Akamatsu; Reiko Kuwahara; Manabu Ohyama; Masayuki Amagai; Yumi Matsuzaki; Shinya Yamanaka; Hideyuki Okano; Yutaka Kawakami
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

View more
  6 in total

1.  BMP2 gene delivery to bone mesenchymal stem cell by chitosan-g-PEI nonviral vector.

Authors:  Jianhui Yue; Jun Wu; Di Liu; Xiaoli Zhao; William W Lu
Journal:  Nanoscale Res Lett       Date:  2015-04-29       Impact factor: 4.703

2.  Induction of hair follicle dermal papilla cell properties in human induced pluripotent stem cell-derived multipotent LNGFR(+)THY-1(+) mesenchymal cells.

Authors:  Ophelia Veraitch; Yo Mabuchi; Yumi Matsuzaki; Takashi Sasaki; Hironobu Okuno; Aki Tsukashima; Masayuki Amagai; Hideyuki Okano; Manabu Ohyama
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

Review 3.  Use of human intra-tissue stem/progenitor cells and induced pluripotent stem cells for hair follicle regeneration.

Authors:  Manabu Ohyama
Journal:  Inflamm Regen       Date:  2019-02-25

Review 4.  Mitochondrial microRNAs: A Putative Role in Tissue Regeneration.

Authors:  Sílvia C Rodrigues; Renato M S Cardoso; Filipe V Duarte
Journal:  Biology (Basel)       Date:  2020-12-21

5.  FLIM for Evaluation of Difference in Metabolic Status between Native and Differentiated from iPSCs Dermal Papilla Cells.

Authors:  Alena Kashirina; Alena Gavrina; Artem Mozherov; Dmitriy Kozlov; Daria Kuznetsova; Ekaterina Vorotelyak; Elena Zagaynova; Ekaterina Kalabusheva; Aleksandra Kashina
Journal:  Cells       Date:  2022-09-01       Impact factor: 7.666

Review 6.  Alteration of skin properties with autologous dermal fibroblasts.

Authors:  Rajesh L Thangapazham; Thomas N Darling; Jon Meyerle
Journal:  Int J Mol Sci       Date:  2014-05-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.